Madam
Apologies I should have been clearer.
My reference to end of 2017 assumes that US$250m will need to be raised from more than one partner, so assuming MNK sign on and inject e.g. US$125m non-dilutive in Aug17, then the other US$125m could come in the remainder of 2017.
So by the end of 2017, we could have US$250m from two partners (or more).
Of course there could be a deal from Japan/China, a priority review voucher for aGVHD that could spruce up the cash position between now and then.
Then ofcourse there is a chance that non of the above occurs, but if they do - then we are looking at a substantial re-rating, and a well deserved one at that.
Madam Apologies I should have been clearer. My reference to end...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.025(1.88%) |
Mkt cap ! $1.547B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.35 | $1.990M | 1.454M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 7439 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 6643 | 1 |
View Market Depth
| Last trade - 11.40am 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |